Matt Baum will do his residency in the research track in psychiatry at Brigham and Women’s Hospital in Boston starting in July. Matt has completed his MD PhD in a joint Harvard Medical School/MIT program that concentrates on translational research and incorporating engineering into medicine. The experimental neuroscience research of his most recent rotation is focused on investigating the role of the brain's resident immune cells in normal brain development and how dysregulation of those cells contributes to schizophrenia.

Matt is a 2010 Mitchell Scholar. He received a Master's Degree in Neuroscience from Trinity College Dublin. His thesis research examined the molecular basis of schizophrenia and bipolar disorder. Matt was especially impressed by the neuro-engineering component of his studies at Trinity where he was exposed to brain-computer interfaces and their potential application in helping the disabled overcome a variety of mobility and communication challenges. Matt then went to Oxford where he received a DPhil in Neuroethics. In 2016, his book “The Neurotics of Biomarkers” was published by Oxford University Press.

Matt would like to combine medical practice in psychiatry specializing in schizophrenia and bipolar disorder with translational research. He also wants to contribute, as a clinician and researcher, to ongoing policy discussions on the ethical and social issues surrounding mental illness.

Matt obtained his undergraduate degree from Yale.